CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.61−0.00 (-0.33%)
Close on Nov 17, 2026Market cap $16.28MP/E –Yield –
CVRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CVRx's operating cash flow for the twelve months ending Jun 30, 2026 was -$40.46M. For fiscal 2025 it was -$40.17M. The highest annual figure on record is -$16.10M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$40.17M | – |
| FY2024 | Dec 31, 2024 | -$39.14M | – |
| FY2023 | Dec 31, 2023 | -$39.02M | – |
| FY2022 | Dec 31, 2022 | -$42.68M | – |
| FY2021 | Dec 31, 2021 | -$27.73M | – |
| FY2020 | Dec 31, 2020 | -$16.10M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.83M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.16M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.77M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.01M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.41M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.90M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.84M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.13M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.25M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.84M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.10M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.02M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.08M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.16M | – |
See a number that looks wrong?